AVEO Pharmaceuticals

Aveo CEO Michael Bailey

Biotech

After surprise FDA win, Aveo reverts to normal as partner splits

After getting an FDA approval for its long-suffering cancer med from the FDA this month, Aveo’s brief positive news was upset by reverting to type.

Ben Adams Mar 15, 2021 8:55am

Aveo CEO Michael Bailey

Aveo regains full rights to ficlatuzumab as partner splits

Sep 8, 2020 8:54am

COVID-19

Aveo gives up on ficlatuzumab in AML, citing COVID-19

Mar 30, 2020 7:15am

lymphocytes

FDA tells Aveo no, again, for tivozanib

Nov 4, 2019 7:43am

FDA Building

Aveo tanks after FDA feedback on OS data delays tivozanib filing

Feb 1, 2019 10:25am

Novartis headquarters

Novartis dumps Aveo drug as relationship sours

Jul 3, 2018 9:38am